KR870700608A - Amino-salicylic acid derivatives and pharmaceutical compositions - Google Patents

Amino-salicylic acid derivatives and pharmaceutical compositions

Info

Publication number
KR870700608A
KR870700608A KR1019860700507A KR860700507A KR870700608A KR 870700608 A KR870700608 A KR 870700608A KR 1019860700507 A KR1019860700507 A KR 1019860700507A KR 860700507 A KR860700507 A KR 860700507A KR 870700608 A KR870700608 A KR 870700608A
Authority
KR
South Korea
Prior art keywords
amino
pharmaceutical compositions
acid derivatives
salicylic acid
salicylic
Prior art date
Application number
KR1019860700507A
Other languages
Korean (ko)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR870700608A publication Critical patent/KR870700608A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
KR1019860700507A 1984-11-29 1986-07-28 Amino-salicylic acid derivatives and pharmaceutical compositions KR870700608A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY
PCT/EP1985/000645 WO1986003199A1 (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
KR870700608A true KR870700608A (en) 1987-12-30

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860700507A KR870700608A (en) 1984-11-29 1986-07-28 Amino-salicylic acid derivatives and pharmaceutical compositions

Country Status (12)

Country Link
EP (1) EP0236329A1 (en)
JP (1) JPS62501703A (en)
KR (1) KR870700608A (en)
CN (1) CN85109554A (en)
AU (1) AU5231186A (en)
DK (1) DK346486D0 (en)
ES (1) ES8701717A1 (en)
GR (1) GR852834B (en)
IT (1) IT1196348B (en)
PT (1) PT81566B (en)
WO (1) WO1986003199A1 (en)
ZA (1) ZA859035B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (en) * 1990-09-12 1994-09-12 Depha Team Srl DERIVATIVES OF 5-AMINOSALICYLIC ACID (5-ASA) FOR THE THERAPY OF CHRONIC INTESTINAL INFLAMMATIONS
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (en) * 1995-09-01 1997-10-31 Synthelabo USE OF SULPHASALAZINE AND ITS METABOLITES FOR THE MANUFACTURE OF A MEDICAMENT USEFUL IN THE TREATMENT OF VENOUS INSUFFICIENCY AND VENOUS ULCERS
DK1274675T3 (en) * 2000-04-19 2004-12-06 Neurotech Co Ltd Compounds, Compositions and Methods for Preventing Neurodegeneration in Acute and Chronic Nervous System Injuries
US6573402B1 (en) 2000-04-20 2003-06-03 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
DE60114724T2 (en) * 2000-07-18 2006-06-01 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blood flow improvers and preparations for the prevention or cure of thrombosis
DE60136260D1 (en) 2001-01-19 2008-12-04 Apex Biotechnology Corp Non-enzymatic detergent-containing disposable electrical strips for the detection of uric acid or hemoglobin, as well as methods for the production and use of the same
CA2465978C (en) 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
JP4113957B2 (en) 2002-06-19 2008-07-09 アムコア ファーマ, インコーポレイテッド Tetrafluorobenzyl derivative and pharmaceutical composition for prevention and treatment of acute and degenerative cranial nervous system diseases containing the same
KR100668111B1 (en) 2005-07-28 2007-01-12 (주)에스에이치제약 New aminosalicylic acid analogs, it's pharmaceutically acceptable salts and their preparations
ES2690205T3 (en) 2006-04-13 2018-11-19 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition to treat or prevent inflammatory diseases
CN100422721C (en) * 2006-05-26 2008-10-01 南京大学 Aluminium ion investigating method using glycosyl naphthol
AU2008314979A1 (en) * 2007-10-23 2009-04-30 Institute Of Medicinal Molecular Design, Inc. Inhibitor of PAI-1 production
KR100852962B1 (en) 2007-11-12 2008-08-20 주식회사 뉴로테크 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
KR101708065B1 (en) * 2008-07-08 2017-02-17 카타베이시스 파마슈티칼즈, 인코포레이티드 Fatty acid acetylated salicylates and their uses
KR101204108B1 (en) * 2009-02-09 2012-11-22 주식회사 지엔티파마 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
WO2011028689A1 (en) 2009-09-01 2011-03-10 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
CA2873096A1 (en) * 2012-05-23 2013-11-28 Cellixbio Private Limited Compositions and methods for the treatment of inflammatory bowel disease
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
JP2022515520A (en) * 2018-12-28 2022-02-18 ジーエヌティー ファーマ カンパニー, リミテッド Compositions for treating neurodegenerative disorders and methods for treating them
CN111116395B (en) * 2019-12-27 2023-04-07 湖北工业大学 Multi-iodo aromatic acid compound and application thereof in resisting adenovirus 7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (en) * 1964-06-09 1966-11-02
NL7008623A (en) * 1969-06-25 1970-12-29
JPS5640710B2 (en) * 1973-01-18 1981-09-22
JPS6056130B2 (en) * 1978-03-20 1985-12-09 久光製薬株式会社 Novel salicylic acid derivatives
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
IT1196348B (en) 1988-11-16
CN85109554A (en) 1986-07-23
EP0236329A1 (en) 1987-09-16
ZA859035B (en) 1986-08-27
DK346486A (en) 1986-07-21
PT81566A (en) 1985-12-01
ES8701717A1 (en) 1986-12-01
JPS62501703A (en) 1987-07-09
ES549359A0 (en) 1986-12-01
PT81566B (en) 1987-04-07
WO1986003199A1 (en) 1986-06-05
DK346486D0 (en) 1986-07-21
IT8423799A0 (en) 1984-11-29
GR852834B (en) 1986-03-27
AU5231186A (en) 1986-06-18

Similar Documents

Publication Publication Date Title
KR870700608A (en) Amino-salicylic acid derivatives and pharmaceutical compositions
DK330287D0 (en) ANTI-INFLAMMATORY RELATIONSHIP AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
NZ211031A (en) 6-substituted-4-dialkylaminotetrahindole derivatives and pharmaceutical compositions
NZ218588A (en) Benzoic acid derivatives and pharmaceutical compositions
IT1214683B (en) NASAL PHARMACEUTICAL COMPOSITIONS
NZ213461A (en) 1,4-dihyrdropyridine-3,5-dicarboxylic acid derivatives and pharmaceutical compositions
NZ212499A (en) Substituted benzamide derivatives and pharmaceutical compositions
IT1209615B (en) PHARMACEUTICAL COMPOSITION
KR870700618A (en) Chromoglic acid derivatives and preparation method and pharmaceutical composition
NZ210818A (en) 8-alpha-acylaminoergoline derivatives and pharmaceutical compositions
IL72157A (en) 6-alpha-hydroxyethyl-2-substituted-2-penem-3-carboxylic acid derivatives and pharmaceutical compositions comprising them
NZ216546A (en) Glycerol derivatives and pharmaceutical compositions
NZ224923A (en) 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions
NZ215174A (en) Barbituric acid derivatives and pharmaceutical compositions
NZ212868A (en) Phenylnonatetraenoic acid derivatives and pharmaceutical compositions and intermediates therefor
DK99085D0 (en) PHARMACEUTICAL PREPARATIONS CONTAINING A-VITAMIC ACID DERIVATIVES
NZ214284A (en) Benzamide derivatives and pharmaceutical compositions
NZ221018A (en) 2-penem-3-carboxylic acid derivatives and pharmaceutical compositions
DK317985D0 (en) AMINOEBURNANCARBOXYLIC ACID DERIVATIVES
NZ210817A (en) N-hydroxy-alkoxynaphthalinalkanamine derivatives and pharmaceutical compositions
IT1216814B (en) PHARMACEUTICAL COMPOSITIONS
PH24338A (en) Nitroapovincaminic acid derivatives and pharmaceutical compositions containing them
IT1203737B (en) PHARMACEUTICAL COMPOSITIONS INCLUDING 3-AMINOPROPOSSI-INDOLI
IT8547703A1 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING BROMOCRYPTINE
NO850386L (en) N-SUBSTITUTED AMINOPROPANSULPHONIC ACID DERIVATIVES

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application